| Clinical Research Associate |
Toranomon (NPKK Head Office) |
Japan |
Development |
Universal Hierarchy Node |
Research & Development |
Μαρ 31, 2025 |
| Manager, Product Brand Comms |
Toranomon (NPKK Head Office) |
Japan |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Μαρ 30, 2025 |
| Expert Regulatory Writer |
Toranomon (NPKK Head Office) |
Japan |
Development |
Universal Hierarchy Node |
Research & Development |
Μαρ 27, 2025 |
| Senior Regulatory Writer |
Toranomon (NPKK Head Office) |
Japan |
Development |
Universal Hierarchy Node |
Research & Development |
Μαρ 27, 2025 |
| Associate Director, Early Strategic Partnerships |
Toranomon (NPKK Head Office) |
Japan |
Biomedical Research |
Pharma Research |
BD&L & Strategic Planning |
Μαρ 25, 2025 |
| Senior Clinical Sciences Trial Leader |
Toranomon (NPKK Head Office) |
Japan |
Biomedical Research |
Pharma Research |
Research & Development |
Μαρ 25, 2025 |
| Associate/Manager, MSL（Solid Tumor） |
Toranomon (NPKK Head Office) |
Japan |
International |
Innovative Medicines |
Research & Development |
Μαρ 24, 2025 |
| Production Operator |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Technical Operations |
Μαρ 24, 2025 |
| SCM expert |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Technical Operations |
Μαρ 24, 2025 |
| Field Technical Expert (Radio Ligand Therapy) |
Toranomon (NPKK Head Office) |
Japan |
International |
Innovative Medicines |
Market Access |
Μαρ 23, 2025 |
| Senior Manager, BPA Operations |
Toranomon (NPKK Head Office) |
Japan |
Finance |
Universal Hierarchy Node |
Audit & Finance |
Μαρ 19, 2025 |
| Submission Manager Japan |
Toranomon (NPKK Head Office) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Μαρ 19, 2025 |
| Manager, RA CMC Manager Japan |
Toranomon (NPKK Head Office) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Μαρ 13, 2025 |
| Japan Program Head (Immunology) |
Toranomon (NPKK Head Office) |
Japan |
Development |
Universal Hierarchy Node |
Research & Development |
Μαρ 13, 2025 |
| Japan Program Clinical Head |
Toranomon (NPKK Head Office) |
Japan |
Biomedical Research |
Universal Hierarchy Node |
Research & Development |
Μαρ 13, 2025 |
| Country Head of Quality (Japan) |
Toranomon (NPKK Head Office) |
Japan |
Operations |
Innovative Medicines |
Quality |
Μαρ 12, 2025 |
| Japan Program Head (Neuroscience & GTx) |
Toranomon (NPKK Head Office) |
Japan |
Development |
Universal Hierarchy Node |
Research & Development |
Μαρ 12, 2025 |
| Senior Specialist, IT Information Security Compliance |
Toranomon (NPKK Head Office) |
Japan |
Operations |
CTS |
Technology Transformation |
Μαρ 06, 2025 |
| Senior Lead, New Product Planning & Launch Excellence |
Toranomon (NPKK Head Office) |
Japan |
Strategy & Growth |
Innovative Medicines |
Marketing |
Μαρ 06, 2025 |
| Manager, People and Culture Communications |
Toranomon (NPKK Head Office) |
Japan |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Μαρ 04, 2025 |
| Associate, Automation Engineer |
Sasayama |
Japan |
Operations |
|
Technical Operations |
Μαρ 04, 2025 |
| Lead, RWE and Evidence Excellence |
Toranomon (NPKK Head Office) |
Japan |
International |
Innovative Medicines |
Research & Development |
Μαρ 04, 2025 |
| Senior Lead, Cx Content Creation |
Toranomon (NPKK Head Office) |
Japan |
International |
Innovative Medicines |
Marketing |
Φεβ 17, 2025 |
| Site HSE Head Commercial Operations Japan |
Tokyo (NPKK Sales) |
Japan |
Operations |
CTS |
Facilities & Administration |
Φεβ 16, 2025 |
| Manager DDIT Strategic Business Partner |
Toranomon (NPKK Head Office) |
Japan |
Operations |
CTS |
Technology Transformation |
Φεβ 04, 2025 |
| Business Partner |
Toranomon (NPKK Head Office) |
Japan |
People & Organization |
Universal Hierarchy Node |
Human Resources |
Ιαν 31, 2025 |
| Lead, Pricing & Public Policy |
Toranomon (NPKK Head Office) |
Japan |
International |
Innovative Medicines |
Market Access |
Ιαν 28, 2025 |
| Sr Manager, Executive Communications |
Toranomon (NPKK Head Office) |
Japan |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ιαν 23, 2025 |
| Sr Manager, Growth Strategy and Policy Communications |
Toranomon (NPKK Head Office) |
Japan |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ιαν 23, 2025 |
| Group Manager, Brand and Reputation |
Toranomon (NPKK Head Office) |
Japan |
Corporate Affairs |
CTS |
Communications & Public Affairs |
Ιαν 23, 2025 |
| Senior Business Analyst DDIT IM JP&APMA Analyst & Patient |
Toranomon (NPKK Head Office) |
Japan |
Operations |
CTS |
Technology Transformation |
Ιαν 22, 2025 |
| Japan Program Manager |
Toranomon (NPKK Head Office) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Ιαν 08, 2025 |
| Sr Manager / Manager, Global Program Regulatory Manager (GPRM) Japan |
Toranomon (NPKK Head Office) |
Japan |
Development |
Innovative Medicines |
Research & Development |
Ιαν 05, 2025 |
| MS&T Expansion Lead RLT Sasayama |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Technical Operations |
Δεκ 16, 2024 |
| Investigation Expert |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Δεκ 16, 2024 |
| Clinical Biospecimen Senior Scientist |
Toranomon (NPKK Head Office) |
Japan |
Development |
Universal Hierarchy Node |
Research & Development |
Δεκ 03, 2024 |
| Head Regulatory Writing |
Toranomon (NPKK Head Office) |
Japan |
Development |
Universal Hierarchy Node |
Research & Development |
Δεκ 03, 2024 |
| Associate or Manager, PHAD Japan |
Toranomon (NPKK Head Office) |
Japan |
Development |
Universal Hierarchy Node |
Research & Development |
Δεκ 03, 2024 |
| Customer Engagement Lead |
Toranomon (NPKK Head Office) |
Japan |
International |
Innovative Medicines |
Sales |
Δεκ 03, 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Οκτ 18, 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Οκτ 18, 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Οκτ 18, 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Οκτ 18, 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Οκτ 18, 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Οκτ 18, 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Οκτ 18, 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Οκτ 18, 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Οκτ 18, 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Οκτ 18, 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Οκτ 18, 2024 |